<DOC>
	<DOCNO>NCT02511587</DOCNO>
	<brief_summary>FSME-Immun® register application muscle . This study investigate application skin lead comparable immune response .</brief_summary>
	<brief_title>Comparison Vaccination Routes : Subcutaneous Versus Intramuscular Application FSME-Immun®</brief_title>
	<detailed_description>Tick-borne encephalitis ( TBE ) vaccine ( FSME-Immun® ) register intra-muscular application . Due medical reason ( e.g . anticoagulant therapy , adipositas ) intra-muscular application always possible . The aim clinical trial investigate whether comparably good immunogenicity achieve via subcutaneous vaccination route . Thus humoral cellular immune response intramuscular subcutaneous TBE vaccination healthy volunteer compare .</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<criteria>complete primary TBE immunization + least one booster immunization adult sex 18 60 year age willingness sign write informed consent form age &lt; 18 &gt; 60 year prior TBE infection pregnancy breast feed acute infection day inclusion ( day 0 ) , ( body temperature &gt; 37,9°C ) concomitant medication : systemic cortisone therapy , chemotherapy , immunosuppressive therapy 4 week prior study administration vaccine 4 week before/after day 0 plan surgery within 2 week before/after TBE booster vaccination specific immunotherapy ( Hypo/Desensibilisation ) 14 day before/after vaccination contraindication administration FSMEImmun® vaccine accord manufacturer 's instruction history malignant disease within last 5 year autoimmune disease drug addiction plasma donor receipt blood transfusion immuno globulin within 3 month study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>